Verona Pharma Announces June 2025 Investor Conference Participation
Verona Pharma (Nasdaq: VRNA) has announced its participation in two major healthcare investor conferences in June 2025. The company's senior management will engage in fireside chats at the Jefferies Global Healthcare Conference on June 4, 2025, at 11:05 a.m. ET in New York, and the Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025, at 2:40 p.m. ET in Miami. Webcasts of both presentations will be accessible through the Events and Presentations section on Verona Pharma's investor website.
Verona Pharma (Nasdaq: VRNA) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel settore sanitario a giugno 2025. Il management senior dell'azienda parteciperà a colloqui informali durante la Jefferies Global Healthcare Conference il 4 giugno 2025 alle 11:05 ET a New York, e alla Goldman Sachs 46th Annual Global Healthcare Conference il 9 giugno 2025 alle 14:40 ET a Miami. Le dirette streaming di entrambe le presentazioni saranno disponibili nella sezione Eventi e Presentazioni del sito web per investitori di Verona Pharma.
Verona Pharma (Nasdaq: VRNA) ha anunciado su participación en dos importantes conferencias para inversores en el sector sanitario en junio de 2025. La alta dirección de la empresa participará en charlas informales en la Jefferies Global Healthcare Conference el 4 de junio de 2025 a las 11:05 a.m. ET en Nueva York, y en la Goldman Sachs 46th Annual Global Healthcare Conference el 9 de junio de 2025 a las 2:40 p.m. ET en Miami. Las retransmisiones en línea de ambas presentaciones estarán disponibles en la sección de Eventos y Presentaciones del sitio web para inversores de Verona Pharma.
Verona Pharma (나스닥: VRNA)는 2025년 6월 두 개의 주요 헬스케어 투자자 컨퍼런스에 참여한다고 발표했습니다. 회사의 고위 경영진은 2025년 6월 4일 오전 11시 05분(동부시간) 뉴욕에서 열리는 Jefferies Global Healthcare Conference와 2025년 6월 9일 오후 2시 40분(동부시간) 마이애미에서 열리는 Goldman Sachs 46th Annual Global Healthcare Conference에서 대화형 세션에 참여할 예정입니다. 두 발표 모두 Verona Pharma 투자자 웹사이트의 이벤트 및 프레젠테이션 섹션을 통해 웹캐스트로 시청할 수 있습니다.
Verona Pharma (Nasdaq : VRNA) a annoncé sa participation à deux grandes conférences pour investisseurs dans le secteur de la santé en juin 2025. La direction de l’entreprise prendra part à des discussions informelles lors de la Jefferies Global Healthcare Conference le 4 juin 2025 à 11h05 (heure de l’Est) à New York, ainsi qu’à la Goldman Sachs 46th Annual Global Healthcare Conference le 9 juin 2025 à 14h40 (heure de l’Est) à Miami. Les webdiffusions des deux présentations seront accessibles via la section Événements et Présentations du site web investisseurs de Verona Pharma.
Verona Pharma (Nasdaq: VRNA) hat die Teilnahme an zwei wichtigen Gesundheitsinvestorenkonferenzen im Juni 2025 angekündigt. Das Führungsteam des Unternehmens wird am 4. Juni 2025 um 11:05 Uhr ET in New York bei der Jefferies Global Healthcare Conference sowie am 9. Juni 2025 um 14:40 Uhr ET in Miami bei der Goldman Sachs 46th Annual Global Healthcare Conference in informellen Gesprächen teilnehmen. Webcasts beider Präsentationen sind im Bereich Veranstaltungen und Präsentationen auf der Investorenseite von Verona Pharma verfügbar.
- None.
- None.
LONDON and RALEIGH, N.C., May 21, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that senior management will participate in fireside chats at the following conferences in June 2025:
Jefferies Global Healthcare Conference
Date: Wednesday, June 4, 2025
Time: 11:05 a.m. ET / 4:05 p.m. BST
Location: New York, NY
Goldman Sachs 46th Annual Global Healthcare Conference
Date: Monday, June 9, 2025
Time: 2:40 p.m. ET / 7:40 p.m. BST
Location: Miami, FL
A webcast of each conference presentation will be available on the Events and Presentations link on the Investors page of the Company’s website, www.veronapharma.com.
For further information please contact:
| Verona Pharma plc | Tel: +1-844-341-9901 |
| Victoria Stewart, Senior Director of Investor Relations and Communications | IR@veronapharma.com |
| Argot Partners US Investor Enquiries | Tel: +1-212-600-1902 verona@argotpartners.com |
| Ten Bridge Communications International / US Media Enquiries | Tel: +1-781-316-4424 tbcverona@tenbridgecommunications.com |
| Wendy Ryan |
About Verona Pharma
Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs. Ohtuvayre® (ensifentrine) is the Company’s first commercial product and the first inhaled therapy for the maintenance treatment of COPD that combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule. Ensifentrine has potential applications in non-cystic fibrosis bronchiectasis, cystic fibrosis, asthma and other respiratory diseases. For more information, please visit www.veronapharma.com.
FAQ
What investor conferences will Verona Pharma (VRNA) attend in June 2025?
When is Verona Pharma's presentation at the Jefferies Global Healthcare Conference 2025?
How can investors access Verona Pharma's June 2025 conference presentations?
What time is Verona Pharma's presentation at the Goldman Sachs Healthcare Conference 2025?
